Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 426,749 | 1,380,033 | 1,087,906 | 689,507 | 302,366 |
| Depreciation Amortization | 97,453 | 365,648 | 268,772 | 174,569 | 83,945 |
| Income taxes - deferred | -66,525 | -116,900 | -86,858 | -43,831 | -3,876 |
| Accounts receivable | -75,546 | 3,571 | 18,486 | -10,758 | -89,066 |
| Other Working Capital | -282,053 | 103,728 | 13,792 | -29,436 | -191,133 |
| Other Operating Activity | 78,861 | 143,817 | 69,892 | 50,155 | 92,389 |
| Operating Cash Flow | $178,939 | $1,879,897 | $1,371,990 | $830,206 | $194,625 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -33,289 | -254,548 | -185,511 | -127,447 | 769,883 |
| Net Acquisitions | N/A | -72,401 | -72,401 | -72,401 | -72,401 |
| Purchase Of Investment | -1,160,680 | -3,334,434 | -2,192,343 | -1,253,934 | -677,092 |
| Sale Of Investment | 4,329,506 | 2,749,558 | 1,913,381 | 1,423,931 | N/A |
| Other Investing Activity | -2,979,596 | -38,517 | -38,014 | -22,647 | -19,772 |
| Investing Cash Flow | $155,941 | $-950,342 | $-574,888 | $-52,498 | $618 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 200,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | -450,000 | -2,428 | N/A | 0 | N/A |
| Common Stock Issued | 21,817 | 67,493 | 58,278 | 43,081 | 24,080 |
| Common Stock Repurchased | -41,023 | -984,715 | -963,171 | -909,951 | -463,171 |
| Other Financing Activity | 30,782 | 42,172 | 42,939 | 33,166 | 22,827 |
| Financing Cash Flow | $-238,424 | $-877,478 | $-861,954 | $-833,704 | $-416,264 |
| Exchange Rate Effect | -3,875 | 4,102 | 2,033 | -1,735 | 4,618 |
| Beginning Cash Position | 570,721 | 514,542 | 514,542 | 514,542 | 514,542 |
| End Cash Position | 663,302 | 570,721 | 451,723 | 456,811 | 298,139 |
| Net Cash Flow | $92,581 | $56,179 | $-62,819 | $-57,731 | $-216,403 |
| Free Cash Flow | |||||
| Operating Cash Flow | 178,939 | 1,879,897 | 1,371,990 | 830,206 | 194,625 |
| Capital Expenditure | -33,289 | -254,548 | -185,511 | -127,447 | -54,551 |
| Free Cash Flow | 145,650 | 1,625,349 | 1,186,479 | 702,759 | 140,074 |